Home
Congresses
- 2026
- 2025
STiP
Webinars
- ESDO – GI Cancer – ASCO GI 2026
- ESDO GI Cancer – ESMO 2025
Contact
Other specialties
SIGN UP
SIGN IN
- Login
- Account

STiP │ Congress Highlights

DESTINY-Breast03 trial

6 May 2026

Five-year follow-up of DESTINY-Breast03: T-DXd vs T-DM1 in HER2+ MBC

Presented by Dr Andrea Gombos (Institut Jules Bordet, Belgium)

Share Article

Website created by MediMix © 2026 - Privacy Policy

Home
Congresses
- 2026
- 2025
STiP
Webinars
- ESDO – GI Cancer – ASCO GI 2026
- ESDO GI Cancer – ESMO 2025
Contact
Other specialties
SIGN UP
SIGN IN
- Login
- Account

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.